References
- Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med. 2008;359(21):2254–2265. doi: 10.1056/NEJMra0804411.
- Ballas SK. Current issues in sickle cell pain and its management. Hematology Am Soc Hematol Educ Program. 2007;2007(1):97–105. doi: 10.1182/asheducation-2007.1.97.
- Bainbridge R, Higgs DR, Maude GH, Serjeant GR. Clinical presentation of homozygous sickle cell disease. J Pediatr. 1985;106(6):881–885.
- Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11–16. doi: 10.1056/NEJM199107043250103.
- U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. (2002). The Management of Sickle Cell Disease. (NIH Publication No. 02-2117). Available at: http://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf. Accessed May 24, 2016.
- U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. (2014). Evidence Based Management of Sickle Cell Disease. Available at: http://www.nhlbi.nih.gov/health-pro/guidelines/sickle-cell-disease-guidelines. Accessed May 24, 2016.
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins. Hopkins Opioid Program website. Available at: http://www.hopweb.org/hop/hop.cfm?cfid=19941223&cftoken=38906731. 2002–2004. Accessed May 24, 2016.
- Gonzalez ER, Bahal N, Hansen LA, et al. Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department. Arch Intern Med. 1991;151(7):1373–1378.
- Van Beers EJ, Van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol 2007;82(11):955–960.